| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
| 08/23/2013 | CA2807524A1 Methods and compositions for treating cancer metastasis |
| 08/22/2013 | WO2013123511A1 Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics |
| 08/22/2013 | WO2013123478A1 Use of immunomodulators for the treatment of cancer |
| 08/22/2013 | WO2013123424A1 Methods and materials for generating cd8+ t cells having the ability to recognize cancer cells expressing a her2/neu polypeptide |
| 08/22/2013 | WO2013123413A2 Combinations of histone deacetylase inhibitor and pazopanib and uses thereof |
| 08/22/2013 | WO2013123227A1 Formulations of bendamustine |
| 08/22/2013 | WO2013122976A1 Osteopontin isoform a inhibitors and methods of use |
| 08/22/2013 | WO2013122823A1 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 08/22/2013 | WO2013122609A1 Methods of using cdk8 antagonists |
| 08/22/2013 | WO2013122545A1 Synergistic combinations for use in treating cancer |
| 08/22/2013 | WO2013122303A1 Novel 2- aminothiazole derivative and anti-cancer composition comprising same as active ingredient |
| 08/22/2013 | WO2013122262A1 Virus like particle composition |
| 08/22/2013 | WO2013121175A1 Lysosome-cleavable linker |
| 08/22/2013 | WO2013120229A1 METHOD FOR PREPARING AQUEOUS MANO PARTICLE SUSPENSIONS OF DERIVATIVES OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURAN ALIPHATIC ACID ESTERS |
| 08/22/2013 | WO2013101983A3 Targeted self-assembly 0f functionalized carbon nanotubes on tumors |
| 08/22/2013 | WO2013100585A3 Adonis amurensis extract or anti-cancer composition using same as an active ingredient |
| 08/22/2013 | WO2013086379A3 Methods and compositions for treating antiprogestin-resistant cancers |
| 08/22/2013 | WO2013064830A3 Medical use |
| 08/22/2013 | WO2013057222A3 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
| 08/22/2013 | US20130217865 Tumor Specific Antibody |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130216561 Immunoconjugates with an Intracellularly-Cleavable Linkage |
| 08/22/2013 | US20130216545 Early Diagnosis and Novel Treatment of Cancer |
| 08/22/2013 | US20130216523 Methods for Facilitating Diagnosis, Prognosis and Treatment of Cancer by Detecting HER1 Expression |
| 08/21/2013 | EP2628751A2 Binding members for interleukin-6 and use thereof |
| 08/21/2013 | EP2628741A2 Novel compound of a reverse-turn mimetic and a production method and use therefor |
| 08/21/2013 | EP2628726A1 Hydroxamate-based inhibitors of deacetylases b |
| 08/21/2013 | EP2628488A1 Sustained-release pharmaceutical composition |
| 08/21/2013 | EP2628485A1 New use of chemical ingredients in cynomorium as phytoestrogen |
| 08/21/2013 | EP2628482A1 Rho kinase inhiitors for use in the treatment of neuroblastoma |
| 08/21/2013 | EP2628480A1 Compounds and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation |
| 08/21/2013 | EP2627674A2 Egfr-based peptides |
| 08/21/2013 | EP2627657A2 Molecular containers and methods of making and using same |
| 08/21/2013 | EP2627648A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS |
| 08/21/2013 | EP2627638A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| 08/21/2013 | EP2627631A1 Pyrrolidinones as metap2 inhibitors |
| 08/21/2013 | EP2627341A2 Coriolus versicolor extracts, methods of preparation and uses thereof |
| 08/21/2013 | EP2627333A1 Combination treatment of cancer |
| 08/21/2013 | EP2627332A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 08/21/2013 | EP2627324A2 Substituted benzamides and their uses |
| 08/21/2013 | EP2627321A1 Treatment of cancer/inhibition of metastasis |
| 08/21/2013 | EP2627316A1 Pharmaceutical formulation for histone deacetylase inhibitors |
| 08/21/2013 | EP2627315A1 Composition for treating cancer by the controlled release of an active substance |
| 08/21/2013 | EP2627179A1 Methods for inhibiting cell proliferation in egfr-driven cancers |
| 08/21/2013 | EP2379497B1 Hemifumarate salt of 1- ý4- ý1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl¨-2 -ethyl-benzyl¨-a zetidine-3-carboxylic acid |
| 08/21/2013 | EP2143437B1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2013 | CN1968717B Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 08/21/2013 | CN103261890A Inhibitors of human ezh2, and methods of use thereof |
| 08/21/2013 | CN103261418A Bispecific aptamers mediating tumour cell lysis |
| 08/21/2013 | CN103261413A Marker for determination of sensitivity to triplet combination anti-cancer agent |
| 08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
| 08/21/2013 | CN103261229A Combination therapy of an afucosylated CD20 antibody with a MDM2 inhibitor |
| 08/21/2013 | CN103261217A Soluble pd-1 variants, fusion constructs, and uses thereof |
| 08/21/2013 | CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 08/21/2013 | CN103261198A 2-arylimidazo[1,2-]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives |
| 08/21/2013 | CN103261197A Highly-soluble pyrroloquinoline quinone salt and method for producing same |
| 08/21/2013 | CN103261196A Pyrazolopyridines as inhibitors of the kinase lrrk2 |
| 08/21/2013 | CN103261186A Dimeric IAP inhibitors |
| 08/21/2013 | CN103261169A Deubiquitinase inhibitors and methods for use of the same |
| 08/21/2013 | CN103261160A Guanidine compounds and compositions for the inhibition of nampt |
| 08/21/2013 | CN103260648A Compositions and methods for the prevention and treatment of cancer |
| 08/21/2013 | CN103257189A (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use |
| 08/21/2013 | CN103255187A Low molecular hyaluronate, preparation method and purpose thereof |
| 08/21/2013 | CN103255172A Inducible shRNA (short hairpin ribonucleic acid) lentiviral expression vector and construction method and application thereof |
| 08/21/2013 | CN103255170A Oncolytic adenovirus construction method for targeted CD47 positive leukemia cells and application thereof |
| 08/21/2013 | CN103255169A Replication-defective arenavirus vectors |
| 08/21/2013 | CN103255137A Method for detecting SKA1 gene expression and purpose of siRNA thereof |
| 08/21/2013 | CN103255076A Bacillus spp and hyaluronidase and preparation method and purpose thereof |
| 08/21/2013 | CN103255068A Paraconiothyrium sp. |
| 08/21/2013 | CN103255042A Sea cucumber health-care wine and brewing method thereof |
| 08/21/2013 | CN103255022A Eucommia ulmoides male flower wine and preparation method thereof |
| 08/21/2013 | CN103254321A Method for extracting and purifying Phellinus vaninii polysaccharides of medicinal fungus Phellinus vaninii |
| 08/21/2013 | CN103254317A Anti-CD20 monoclonal antibody-aplysiatoxin conjugate as well as preparation method and application thereof |
| 08/21/2013 | CN103254313A Combined CTL antigenic epitope and its application |
| 08/21/2013 | CN103254304A Immune stimulant couplet, preparation method thereof and antineoplastic application of the immune stimulant couplet |
| 08/21/2013 | CN103254303A Preparation method and application of antineoplastic active polypeptide component in Arca subcrenata Lischke |
| 08/21/2013 | CN103254302A Method for separation of antitumor polypeptide compound from Arca subcrenata Lischke and application |
| 08/21/2013 | CN103254289A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254287A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254284A Tubulin depolymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254283A Tubulin polymerizing agent polypeptides and application thereof |
| 08/21/2013 | CN103254282A Tubulin depolymerizing agent polypeptides 5 and application thereof |
| 08/21/2013 | CN103254281A Tubulin polymerizing agent polypeptides 6 and application thereof |
| 08/21/2013 | CN103254280A Short peptide with tumor cell targeting combination capability and application thereof |
| 08/21/2013 | CN103254279A Polypeptide conjugate of paclitaxel or docetaxel |
| 08/21/2013 | CN103254269A A,B-cyclobilactam steroid compound and synthetic method thereof and application A,B-cyclobilactam steroid compound of in preparing antitumor drugs |
| 08/21/2013 | CN103254266A Steroid zinc metal complex and preparation method thereof as well as application of complex in preparation of antitumor medicines |
| 08/21/2013 | CN103254264A Pregnenolone aromatic aldehydes azine steroid compound and synthetic method thereof as well as application of compound in preparation of antitumor medicines |
| 08/21/2013 | CN103254263A Cardiac glycoside compound and preparation method as well as application thereof |
| 08/21/2013 | CN103254239A aryl ruthenium-beta-carboline complex and its preparation method and application |
| 08/21/2013 | CN103254236A Preparation method of 4-aryl coumarin-3-phosphonate derivatives |
| 08/21/2013 | CN103254223A Silicon phthalocyanine axially modified by aminoethyl phenoxyl and polyethylene glycol oligomer |
| 08/21/2013 | CN103254212A Annonaceous acetogenins derivatives, and preparation method and purpose thereof |
| 08/21/2013 | CN103254205A Spirocyclic derivatives as histone deacetylase inhibitors |
| 08/21/2013 | CN103254203A Five-membered urea ring-coumarin derivative or pharmaceutical salt and application thereof |
| 08/21/2013 | CN103254195A 7-amino-tetrazole[1,5-a] pyrimidine-5-alcohol(compound II) and its synthetic route |
| 08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |